Following a similar approach but in this case with longer expansion in vitro, memory CD4+ T cells from Guillain–Barré syndrome (GBS) patients were assessed for reactivity against peripheral nervous system (PNS)‐myelin peptide pools [75]. The gene discussed is CD4; the disease is Guillain-Barre syndrome.